Naproxen or Loratadine for bone pain associated with Pegfilgrastim treatment for Breast Cancer patients stages I, II or III.
Participants must be newly diagnosed, no prior chemotherapy, and have at least four (4) cycles of chemotherapy planned (but they can not be weekly treatments).
Exclusions include, but are not limited to: Another cancer within the past five (5) years, current chronic pain, bleeding disorders, chronic use of NSAIDS or steroids, prior use of G-CSF or chemotherapy.
Clinical Trial #B-43:
Radiation with or without Herceptin after surgery for women with Her 2 positive Ductal Carcinoma in situ.
Participants can have Ductal Carcinoma in situ and Lobular Carcinoma in situ, but not invasive. Lumpectomy surgery only. Participation must begin prior to the 120th day from surgery.
Exclusions include, but are not limited to: Contralateral breast cancer, multicentric disease, partial breast radiation, active cardiac disease, uncontrolled blood pressure, history of CHF, cardiomyopathy or a recent MI.
Clinical Trial #97609:
Evaluates the effects of whole breast radiation on the appearance of the breast for women who receive radiation following surgery.
Participants must be in the post-op period with whole breast radiation being planned.
Exclusions include, but are not limited to: prior radiation, concurrent chemotherapy, immediate reconstruction or brachytherapy.
Clinical Trial B-49:
Anthracycline versus Docetaxel with Cytoxin for patients who do not have residual disease but are considered high risk for recurrence or progression.
Participants must have unilateral invasive adenocarcinoma, stage pT1-3, pN0-3b. pN0 participants must be ER/PR negative or T1c+. A sentinel lymph node disection must have been performed.
Exclusions include, but are not limited to: Tumors classified as T4, contralateral or synchronous disease, unstable diabetes or active heart disease.
“You had such excellent speakers here that what they did for me was made me less afraid... so that if anything happened to me, I would know the processes to go through and what to ask for to benefit me as a person.”
